The 36-month beta value for OCX is at 0.90. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
Denise Gardner is a financial journalist with a focus on analyzing and reporting on stock market trends and company performance. With a keen eye for market challenges and analyst recommendations, Denise provides valuable insights into the world of finance and investments. Her articles aim to help readers understand the movements and performance of various stocks and make informed decisions in the market.